EFCAB3
Basic information
Region (hg38): 17:62343941-62416480
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EFCAB3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 16 | 17 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 2 | 2 |
Variants in EFCAB3
This is a list of pathogenic ClinVar variants found in the EFCAB3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-62370328-G-T | Benign (May 21, 2018) | |||
17-62373824-G-C | Benign (Dec 31, 2019) | |||
17-62387341-G-A | not specified | Uncertain significance (Oct 18, 2021) | ||
17-62387399-G-C | not specified | Uncertain significance (Jun 02, 2024) | ||
17-62391831-A-G | not specified | Uncertain significance (Dec 15, 2023) | ||
17-62391835-C-T | Likely benign (Apr 06, 2018) | |||
17-62391899-G-A | not specified | Uncertain significance (Mar 20, 2023) | ||
17-62391923-A-C | not specified | Uncertain significance (Apr 17, 2023) | ||
17-62391927-A-G | not specified | Uncertain significance (Oct 29, 2021) | ||
17-62391930-A-G | not specified | Uncertain significance (Feb 27, 2024) | ||
17-62391965-C-T | Benign/Likely benign (Mar 01, 2023) | |||
17-62393578-G-A | not specified | Uncertain significance (Oct 19, 2021) | ||
17-62395149-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
17-62395190-T-C | Benign (Dec 31, 2019) | |||
17-62406491-G-A | not specified | Uncertain significance (Dec 03, 2021) | ||
17-62406536-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
17-62407143-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
17-62407159-C-A | not specified | Uncertain significance (Jul 13, 2021) | ||
17-62407159-C-G | not specified | Uncertain significance (Jul 27, 2021) | ||
17-62413831-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
17-62416012-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
17-62416018-G-A | not specified | Uncertain significance (Aug 14, 2023) | ||
17-62416121-C-T | Benign (May 08, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EFCAB3 | protein_coding | protein_coding | ENST00000450662 | 12 | 46259 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.48e-9 | 0.773 | 123449 | 29 | 2268 | 125746 | 0.00918 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.759 | 211 | 244 | 0.863 | 0.0000111 | 3250 |
Missense in Polyphen | 68 | 72.784 | 0.93427 | 1058 | ||
Synonymous | -0.621 | 92 | 84.7 | 1.09 | 0.00000383 | 863 |
Loss of Function | 1.50 | 17 | 25.1 | 0.677 | 0.00000140 | 321 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0217 | 0.0215 |
Ashkenazi Jewish | 0.00181 | 0.00179 |
East Asian | 0.000660 | 0.000653 |
Finnish | 0.0458 | 0.0455 |
European (Non-Finnish) | 0.00746 | 0.00738 |
Middle Eastern | 0.000660 | 0.000653 |
South Asian | 0.00138 | 0.00134 |
Other | 0.00584 | 0.00572 |
dbNSFP
Source:
- Pathway
- Pathways in clear cell renal cell carcinoma
(Consensus)
Intolerance Scores
- loftool
- 0.760
- rvis_EVS
- 0.66
- rvis_percentile_EVS
- 84.55
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.194
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Efcab3
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- Cellular component
- Molecular function
- calcium ion binding